Mizuho Raises Elevance Health (NYSE:ELV) Price Target to $505.00
Elevance Health (NYSE:ELV – Free Report) had its price target upped by Mizuho from $455.00 to $505.00 in a research report released on Wednesday morning,Benzinga reports. Mizuho currently has an outperform rating on the stock. ELV has been the topic of several other reports. Truist Financial dropped their price objective on Elevance Health from $520.00 […]
